Journal
LANCET DIABETES & ENDOCRINOLOGY
Volume 4, Issue 3, Pages 265-274Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/S2213-8587(15)00380-0
Keywords
-
Categories
Funding
- Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [302825/2011-8]
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [13/03236-5]
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [13/03236-5] Funding Source: FAPESP
Ask authors/readers for more resources
Central precocious puberty results from the premature activation of the hypothalamic-pituitary-gonadal axis. It mimics physiological pubertal development, although at an inappropriate chronological age (before 8 years in girls and 9 years in boys). It can be attributable to cerebral congenital malformations or acquired insults, but the cause in most cases in girls remains unknown. MKRN3 gene defects have been identified in familial disease, with important basic and clinical results. Indeed, genetic analysis of this gene should be included in the routine clinical investigation of familial and idiopathic cases of central precocious puberty. Gonadotropin-releasing hormone agonists are the gold-standard treatment. The assessment and management of this disease remain challenging for paediatric endocrinologists. In this Series paper, we describe current challenges involving the precise diagnosis and adequate treatment of this disorder.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available